The head of the National Institutes of Health, Francis Collins, if the United States is the first to develop an effective vaccine against the novel coronavirus, it has to quickly share it with the world.
“Certainly if we had a vaccine that works, I would want to be sure as quickly as possible, it is available there (Africa) and in South America — look at Brazil right now,” Collins said
“We have a great deal of responsibility. We, as the richest nation in the world, need not to just take care of ourselves. That would be a terrible outcome.”
The Trump administration has set a goal of producing 300 million doses by January — enough to vaccinate the entire population.
Collins says yes while cautioning that any forecast is based on “a lot of hope.”
“Personally, I would certainly think that should be a matter of greatest attention and not sometime in 2022,” he said.
“Maybe even as soon as the end of this year when we actually have the ability to do so.”